BioXcel Therapeutics Inc banner

BioXcel Therapeutics Inc
F:BX2

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
F:BX2
Watchlist
Price: 2.56 EUR
Market Cap: €96.1m

Intrinsic Value

The intrinsic value of one BX2 stock under the Base Case scenario is 18.38 EUR. Compared to the current market price of 2.56 EUR, BioXcel Therapeutics Inc is Undervalued by 86%.

BX2 Intrinsic Value
18.38 EUR
Undervaluation 86%
Intrinsic Value
Price
Base Case Scenario

Valuation History
BioXcel Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about BX2?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BX2 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BioXcel Therapeutics Inc.

Explain Valuation
Alternatives to BX2

Wall St
Price Targets

Dividends

BioXcel Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

BTAI Insider Trading
Buy and sell transactions by insiders

BX2 News

What is the Intrinsic Value of one BX2 stock?

The intrinsic value of one BX2 stock under the Base Case scenario is 18.38 EUR.

Is BX2 stock undervalued or overvalued?

Compared to the current market price of 2.56 EUR, BioXcel Therapeutics Inc is Undervalued by 86%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett